FathomX

Singapore, Singapore Founded: 2018 • Age: 8 yrs
AI-based software is provided for breast cancer detection in mammograms.
Annual revenue - Latest available
Total funding $2.0M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About FathomX

FathomX is a company based in Singapore (Singapore) founded in 2018 by Hartman Mikael, Amos Heng, Hao Du, and Mengling Feng. FathomX has raised $1.95 million across 2 funding rounds. FathomX offers products and services including FxMammo. FathomX operates in a competitive market with competitors including Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.

  • Headquarter Singapore, Singapore
  • Founders Hartman Mikael, Amos Heng, Hao Du, Mengling Feng
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Fathomx Pte. Ltd.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$13.36 K (USD)
    0
    as on Dec 31, 2020
  • EBITDA
    -$13.36 K (USD)
    0
    as on Dec 31, 2020
  • Total Equity Funding
    $1.95 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.6 M (USD), Seed

    Sep 01, 2022

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of FathomX

FathomX offers a comprehensive portfolio of products and services, including FxMammo.

Product name locked
Category locked
Primary

AI tool to enhance mammogram screening accuracy and efficiency.

People of FathomX

Headcount 10-50
Employee Profiles 13
Employee Profiles
People
Galvin Lian
Director of Business Development
People
Feng Meng Ling
Co-Founder & Chief Scientist
People
Stephen Lim
CEO
People
Gajaraj Sekar
Principal Software Engineer

Unlock access to complete

Funding Insights of FathomX

FathomX has successfully raised a total of $1.95M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.6 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by FathomX

Investments
Premium access

Investment portfolio details for FathomX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - FathomX

Premium access

Detailed financials for FathomX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fathomx Comparisons

FathomX Primary company
Description
AI-based software is provided for breast cancer detection in...
Location
Singapore, Singapore
Founded Year
2018
Annual Revenue
Not available
Net Profit
-$13.36 K (USD)
EBITDA
-$13.36 K (USD)
Employees
Not available
Premium access

Peer comparison for FathomX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of FathomX

FathomX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Precision medicine software for liver disease diagnosis is offered.
Locked Locked Locked
AI-powered solutions for medical imaging diagnostics
Locked Locked Locked
AI-based medical image management and analysis solutions for healthcare organizations
Locked Locked Locked
Provider of AI and SaaS-based medical image based decision support tools
Locked Locked Locked
AI-augmented diagnostic tools for radiology imaging are developed.
Locked Locked Locked
AI-driven solutions for medical diagnostic imaging are developed.
Premium access

Detailed competitors of FathomX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fathomx

Premium access

Complete news archive for FathomX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FathomX

FathomX was founded in 2018 and raised its 1st funding round 3 years after it was founded.

FathomX is headquartered in Singapore, Singapore.

FathomX is a funded company, having raised a total of $1.95M across 2 funding rounds to date.

FathomX was founded in 2018 in Singapore by co-founders Hartman Mikael, Amos Heng, Hao Du, and Mengling Feng. AI-based software is developed for the healthcare sector, focusing on medical imaging. FxMammo is offered as a computer-assisted detection tool to support radiologists in identifying breast cancer on mammography images. Operations are centered in Singapore, with services aimed at improving diagnostic accuracy in radiology.

FathomX's top competitors include Perspectum, Qure.ai and Deeptek.

FathomX offers FxMammo.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available